Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) – Capital One Financial lowered their Q2 2024 EPS estimates for shares of Akoya Biosciences in a research note issued on Monday, May 13th. Capital One Financial analyst T. Chiang now expects that the company will earn ($0.28) per share for the quarter, down from their prior estimate […]
Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) – Stock analysts at Capital One Financial dropped their Q2 2024 earnings per share estimates for Akoya Biosciences in a research note issued on Monday, May 13th. Capital One Financial analyst T. Chiang now expects that the company will post earnings of ($0.28) per share for the quarter, […]
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
KR-HT5 is based on Akoya’s PhenoImager® HT PlatformMARLBOROUGH, Mass. and SHANGHAI, China, May 02, 2024 Akoya Biosciences, Inc. , The Spatial Biology Company®, and Shanghai KR Pharmtech, a.
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.